Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Tuesday, July 1, 2025.
SAB Biotherapeutics, Inc. (NASDAQ:SABS)
Long-Term Downtrend (-90) - SABS is in a strong downtrend that is likely to continue. While SABS is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid SABS?
MarketClub looks at technical strength and momentum to determine if the timing is right for SABS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for SABS
The long-term trend has been DOWN since Jan 28th, 2025 at 2.360
The intermediate-term trend has been DOWN since Jun 13th, 2025 at 1.655
The short-term trend has been DOWN since Jun 27th, 2025 at 1.722
Smart Scan Analysis for SABS
Based on our trend formula, SABS is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 1.770 | 1.776 | 1.699 | 1.776 | +0.021 |
| Prev. Close | Volume | Bid | Ask | Time |
| 1.755 | 2249 | 2025-07-01 15:05:12 |
| 52wk High | 5.01 | 52wk High Date | 2024-12-09 |
| 52wk Low | 1 | 52wk Low Date | 2025-04-04 |
| Average Volume | 15,332 | Shares Outstanding | 9,292 |
| Assets | 38,120,062M | Liabilities | 16,712,563M |
| P/E Ratio | -1.03510000 |